Damora Therapeutics, Inc.
- GLTO
- NASDAQ
- Medical - Pharmaceuticals
- Hematologic Disorder Therapies
- Monoclonal Antibody (CALR)
$21.58
Today −3.36%Quote Jun 4, 2026, 04:02 PM UTC
−10.09%over the last month
Max drawdown −16.1%From 1-month high −16.1%3 months −23.2%
Our viewPro
The call stays with Pro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Market value
$353.2M
Approximate share count
Next earnings
—
Data unavailable
Analyst target
$35.25
+63.3% from here
Floor
—
Data unavailable
Where the price sits
5 analysts
Analyst range, low to high
$10.00$46.00
- Price $21.58
- Resistance $21.61
- Consensus $35.25
The price is right under resistance. Analysts' average target sits about 63% higher. Their range is wide.
The call stays with Pro
7 locked chapters- What to do with this namePro
- Why nowPro
- Why this stockPro
- Section write-upsPro
- Story timelinePro
- News briefPro
- Ask about GLTOPro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Log in — 14 days freeWhere the money comes from
No revenue split by segment on file.
Industry
Medical - Pharmaceuticals
Employees
7
Founded
2011